- Home
- MYND vs SRZN Comparison
MYND vs SRZN Comparison
Compare MYND & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- SRZN
- Stock Information
- Founded
- MYND 1998
- SRZN 2015
- Country
- MYND Cayman Islands
- SRZN United States
- Employees
- MYND N/A
- SRZN N/A
- Industry
- MYND Other Consumer Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- MYND Real Estate
- SRZN Health Care
- Exchange
- MYND Nasdaq
- SRZN Nasdaq
- Market Cap
- MYND 38.8M
- SRZN 37.7M
- IPO Year
- MYND 2017
- SRZN N/A
- Fundamental
- Price
- MYND $0.85
- SRZN $11.74
- Analyst Decision
- MYND
- SRZN Strong Buy
- Analyst Count
- MYND 0
- SRZN 2
- Target Price
- MYND N/A
- SRZN $38.50
- AVG Volume (30 Days)
- MYND 16.8K
- SRZN 12.7K
- Earning Date
- MYND 04-15-2025
- SRZN 05-07-2025
- Dividend Yield
- MYND N/A
- SRZN N/A
- EPS Growth
- MYND N/A
- SRZN N/A
- EPS
- MYND N/A
- SRZN N/A
- Revenue
- MYND $267,380,999.00
- SRZN $10,655,000.00
- Revenue This Year
- MYND N/A
- SRZN N/A
- Revenue Next Year
- MYND N/A
- SRZN N/A
- P/E Ratio
- MYND N/A
- SRZN N/A
- Revenue Growth
- MYND N/A
- SRZN N/A
- 52 Week Low
- MYND $0.61
- SRZN $6.00
- 52 Week High
- MYND $4.69
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- MYND 33.74
- SRZN 51.95
- Support Level
- MYND $0.84
- SRZN $10.34
- Resistance Level
- MYND $0.90
- SRZN $12.93
- Average True Range (ATR)
- MYND 0.08
- SRZN 1.11
- MACD
- MYND 0.01
- SRZN 0.01
- Stochastic Oscillator
- MYND 6.59
- SRZN 42.11
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).